Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages

Christina S. Hirsch, Jerrold J. Ellner, David G. Russell, Elizabeth A. Rich

Research output: Contribution to journalArticle

Abstract

The relative phagocytosis and intracellular fate of Mycobacterium tuberculosis (MTB) (H37Ra) in human alveolar macrophages (AM) and their precursors blood monocytes (MN) was investigated. Uptake of MTB by MN and AM was confirmed by electron microscopy. At an infection ratio of 100:1 (MTB:target cell), the percentage of infected AM and the number of MTB per AM was > MN (p <0.001, p <0.0001, respectively). Uptake of MTB was increased by increasing concentrations of serum and decreased in the presence of heat- inactivated serum. Among complement receptors (CR) CR1, CR3, and CR4, the major CR mediating uptake of MTB by MN were CR1 and CR3, whereas for AM, CR4 was the major CR. When MN and AM were infected with MTB and cultured for up to 7 days, AM limited intracellular growth of MTB more effectively than MN as determined by a CFU assay. MTB stimulated production of TNF-α by mononuclear phagocytes and by AM > MN (p <0.007). Pentoxifylline inhibited TNF-α production by mononuclear phagocytes and concurrently increased MTB growth (AM > MN). A polyclonal neutralizing antibody to TNF-α also increased MTB growth in AM. Thus, AM are more efficient in phagocytosis of MTB than MN, and uptake is mediated through CR4 to a greater extent than CR1 or CR3. The slowed replication of MTB in AM is associated with an increase in TNF-α production, and intracellular growth is promoted by pentoxifylline and neutralizing antibody to TNF-α. These data suggest that AM may play a prominent and efficient role in the primary defense of the lung in tuberculosis through CR-mediated uptake, predominantly CR4, and TNF-α- mediated killing of MTB.

Original languageEnglish (US)
Pages (from-to)743-753
Number of pages11
JournalJournal of Immunology
Volume152
Issue number2
StatePublished - Jan 15 1994
Externally publishedYes

Fingerprint

Complement Receptors
Alveolar Macrophages
Mycobacterium tuberculosis
Tumor Necrosis Factor-alpha
Monocytes
Growth
Neutralizing Antibodies
Phagocytosis
Pentoxifylline
Electron Microscopy
Tuberculosis
Lung

ASJC Scopus subject areas

  • Immunology

Cite this

Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. / Hirsch, Christina S.; Ellner, Jerrold J.; Russell, David G.; Rich, Elizabeth A.

In: Journal of Immunology, Vol. 152, No. 2, 15.01.1994, p. 743-753.

Research output: Contribution to journalArticle

Hirsch, Christina S. ; Ellner, Jerrold J. ; Russell, David G. ; Rich, Elizabeth A. / Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. In: Journal of Immunology. 1994 ; Vol. 152, No. 2. pp. 743-753.
@article{f011f8e75a17408daf8c37ec98bf4664,
title = "Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages",
abstract = "The relative phagocytosis and intracellular fate of Mycobacterium tuberculosis (MTB) (H37Ra) in human alveolar macrophages (AM) and their precursors blood monocytes (MN) was investigated. Uptake of MTB by MN and AM was confirmed by electron microscopy. At an infection ratio of 100:1 (MTB:target cell), the percentage of infected AM and the number of MTB per AM was > MN (p <0.001, p <0.0001, respectively). Uptake of MTB was increased by increasing concentrations of serum and decreased in the presence of heat- inactivated serum. Among complement receptors (CR) CR1, CR3, and CR4, the major CR mediating uptake of MTB by MN were CR1 and CR3, whereas for AM, CR4 was the major CR. When MN and AM were infected with MTB and cultured for up to 7 days, AM limited intracellular growth of MTB more effectively than MN as determined by a CFU assay. MTB stimulated production of TNF-α by mononuclear phagocytes and by AM > MN (p <0.007). Pentoxifylline inhibited TNF-α production by mononuclear phagocytes and concurrently increased MTB growth (AM > MN). A polyclonal neutralizing antibody to TNF-α also increased MTB growth in AM. Thus, AM are more efficient in phagocytosis of MTB than MN, and uptake is mediated through CR4 to a greater extent than CR1 or CR3. The slowed replication of MTB in AM is associated with an increase in TNF-α production, and intracellular growth is promoted by pentoxifylline and neutralizing antibody to TNF-α. These data suggest that AM may play a prominent and efficient role in the primary defense of the lung in tuberculosis through CR-mediated uptake, predominantly CR4, and TNF-α- mediated killing of MTB.",
author = "Hirsch, {Christina S.} and Ellner, {Jerrold J.} and Russell, {David G.} and Rich, {Elizabeth A.}",
year = "1994",
month = "1",
day = "15",
language = "English (US)",
volume = "152",
pages = "743--753",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages

AU - Hirsch, Christina S.

AU - Ellner, Jerrold J.

AU - Russell, David G.

AU - Rich, Elizabeth A.

PY - 1994/1/15

Y1 - 1994/1/15

N2 - The relative phagocytosis and intracellular fate of Mycobacterium tuberculosis (MTB) (H37Ra) in human alveolar macrophages (AM) and their precursors blood monocytes (MN) was investigated. Uptake of MTB by MN and AM was confirmed by electron microscopy. At an infection ratio of 100:1 (MTB:target cell), the percentage of infected AM and the number of MTB per AM was > MN (p <0.001, p <0.0001, respectively). Uptake of MTB was increased by increasing concentrations of serum and decreased in the presence of heat- inactivated serum. Among complement receptors (CR) CR1, CR3, and CR4, the major CR mediating uptake of MTB by MN were CR1 and CR3, whereas for AM, CR4 was the major CR. When MN and AM were infected with MTB and cultured for up to 7 days, AM limited intracellular growth of MTB more effectively than MN as determined by a CFU assay. MTB stimulated production of TNF-α by mononuclear phagocytes and by AM > MN (p <0.007). Pentoxifylline inhibited TNF-α production by mononuclear phagocytes and concurrently increased MTB growth (AM > MN). A polyclonal neutralizing antibody to TNF-α also increased MTB growth in AM. Thus, AM are more efficient in phagocytosis of MTB than MN, and uptake is mediated through CR4 to a greater extent than CR1 or CR3. The slowed replication of MTB in AM is associated with an increase in TNF-α production, and intracellular growth is promoted by pentoxifylline and neutralizing antibody to TNF-α. These data suggest that AM may play a prominent and efficient role in the primary defense of the lung in tuberculosis through CR-mediated uptake, predominantly CR4, and TNF-α- mediated killing of MTB.

AB - The relative phagocytosis and intracellular fate of Mycobacterium tuberculosis (MTB) (H37Ra) in human alveolar macrophages (AM) and their precursors blood monocytes (MN) was investigated. Uptake of MTB by MN and AM was confirmed by electron microscopy. At an infection ratio of 100:1 (MTB:target cell), the percentage of infected AM and the number of MTB per AM was > MN (p <0.001, p <0.0001, respectively). Uptake of MTB was increased by increasing concentrations of serum and decreased in the presence of heat- inactivated serum. Among complement receptors (CR) CR1, CR3, and CR4, the major CR mediating uptake of MTB by MN were CR1 and CR3, whereas for AM, CR4 was the major CR. When MN and AM were infected with MTB and cultured for up to 7 days, AM limited intracellular growth of MTB more effectively than MN as determined by a CFU assay. MTB stimulated production of TNF-α by mononuclear phagocytes and by AM > MN (p <0.007). Pentoxifylline inhibited TNF-α production by mononuclear phagocytes and concurrently increased MTB growth (AM > MN). A polyclonal neutralizing antibody to TNF-α also increased MTB growth in AM. Thus, AM are more efficient in phagocytosis of MTB than MN, and uptake is mediated through CR4 to a greater extent than CR1 or CR3. The slowed replication of MTB in AM is associated with an increase in TNF-α production, and intracellular growth is promoted by pentoxifylline and neutralizing antibody to TNF-α. These data suggest that AM may play a prominent and efficient role in the primary defense of the lung in tuberculosis through CR-mediated uptake, predominantly CR4, and TNF-α- mediated killing of MTB.

UR - http://www.scopus.com/inward/record.url?scp=0028349268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028349268&partnerID=8YFLogxK

M3 - Article

C2 - 8283049

AN - SCOPUS:0028349268

VL - 152

SP - 743

EP - 753

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -